Stephanie Brown

Institute of Cancer Research — United Kingdom

Medicine · Health Sciences

24h-index5.5kcitations77works30.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(11), Prostate Cancer Treatment and Research(11), Advanced Radiotherapy Techniques(10), Colorectal Cancer Screening and Detection(4), Antimicrobial Resistance in Staphylococcus(3)

Publications76 total

(ID: 95) A rapid review of the literature on interventions to increase healthcare professionals’ research capacity and capability
International Journal of Pharmacy Practice·2025Open Access
Two-year toxicity outcomes from PACE-C: Stereotactic Body Radiotherapy (SBRT) versus moderate hypofractionated radiotherapy (MHRT)
International Journal of Radiation Oncology*Biology*Physics·2025
Vaccination hesitancy and conspiracy beliefs associated with COVID-19 vaccination behaviours in young adults in the UK: A cross-sectional cohort study
2025Open Access
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial
The Lancet Oncology·2025· 20 citedOpen Access
1584: NEUROLOGIC AND FUNCTIONAL OUTCOMES OF PEDIATRIC SURVIVORS OF VA ECMO CANNULATED FOR SEPSIS
Critical Care Medicine·2025
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer
New England Journal of Medicine·2024· 174 citedOpen Access
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial
European Urology·2024· 47 citedOpen Access
3395: Acute toxicity from PACE-C comparing Stereotactic Body Radiotherapy (SBRT) with moderate hypofractionation (MHRT)
Radiotherapy and Oncology·2024· 3 cited
Can a mock medication-taking learning activity enable pharmacy students to experience the range of barriers and facilitators to medication adherence? An analysis informed by the Theoretical Domains Framework and COM-B model
Exploratory Research in Clinical and Social Pharmacy·2023· 3 citedOpen Access
5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2023· 49 cited
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
European Journal of Cancer·2023· 2 cited
Results of a pilot risk-based lung cancer screening study: outcomes and comparisons to a Medicare eligible cohort
Discover Oncology·2023· 1 citedOpen Access
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty
European Urology·2023· 31 cited
PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.
Journal of Clinical Oncology·2023· 31 cited
Comparison of 3-Weekly and 6-Weekly Pembrolizumab UK Prescribing Practice for Advanced and Resected Melanoma
SSRN Electronic Journal·2023Open Access
35: EXTRACORPOREAL LIFE SUPPORT AFTER SUCCESSFUL RESUSCITATION FROM PEDIATRIC IN-HOSPITAL CARDIAC ARREST
Critical Care Medicine·2022
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
The Lancet Oncology·2022· 281 citedOpen Access
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases
Radiotherapy and Oncology·2022· 79 citedOpen Access
ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases
Radiotherapy and Oncology·2022· 94 citedOpen Access
Creating National Standard Site-Specific Radiotherapy Consent Forms: A Quality Improvement Project
Clinical Oncology·2022
page 1 of 4Next →

Frequent Co-authors

Alison Tree(11), Peter Ostler(11), Olivia Naismith(11), Shaun Tolan(10), Clare Griffin(10), Emma Hall(10), Stephanie Burnett(9), H. van der Voet(8), William Chu(8), Daniel Ford(8), John Staffurth(8), Suneil Jain(7), Nicholas van As(7), Douglas Brand(6), Kiran Kancherla(6), Aileen Duffton(6), Mathias Winkler(6), Julia Pugh(6), Andrew Loblaw(5), Victoria Hinder(5)